Abbott Molecular gathers forces in new world HQ

Tapping in on the rapidly growing business of genetic testing, Abbott Molecular is gathering 400 workers together in a new worldwide headquarters in Des Plaines, Illinois. The company reports that its testing business is growing at a rate of 30 percent per year and is expected to breach the $200 million mark in a couple of years. Analysts say that the molecular diagnostics industry overall is growing 15 percent to 20 percent per year.

- read this report from The Chicago Tribune for more

Suggested Articles

AbbVie snagged the option to license Harpoon’s anti-BCMA multiple myeloma candidate and the duo added up to six new targets to their discovery deal.

In this week's EuroBiotech Report, Bayer's heart failure drug clears phase 3 test, ABPI calls for more U.K. investment and GHO raises €975 million. 

In our EuroBiotech roundup this week, Azeria raises £32 million, Zealand delays phase 3 readout and Galapagos eyes early 2021 IPF futility analysis.